AACR Annual Meeting 2025

Find lung cancer news and updates from the American Association for Cancer Research (AACR) Annual Meeting 2025, taking place April 25-30, in Chicago, Illinois.

Beamion LUNG-1: Zongertinib Shows ‘Significant’ Activity in Patients With NSCLC Harboring HER2 Mutations

Cecilia BrownConference Coverage | April 28, 2025

John V. Heymach, MD, PhD, of the MD Anderson Cancer Center, presented results from the trial at AACR 2025.

Zoldonrasib Shows ‘Encouraging’ Activity in Patients With NSCLC Harboring KRAS G12D Mutation

Cecilia BrownKRAS+ NSCLC | April 28, 2025

Kathryn C. Arbour, MD, of the Memorial Sloan Kettering Cancer Center, presented results from the study at AACR 2025.

Alice T. Shaw, MD, PhD, to Receive AACR-Joseph H. Burchenal Award for Outstanding Achievement in Clinical Cancer Research

Lung Cancers Today EditorsALK+ NSCLC | April 22, 2025

Dr. Shaw is being recognized for her "groundbreaking work in defining ALK- and ROS1-positive lung cancers," officials said.

Loïc Le Marchand, MD, PhD, MPH, to Receive AACR-American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention

Lung Cancers Today EditorsLung Cancer | April 23, 2025

Dr. Le Marchand’s "seminal work has elucidated racial and ethnic disparities in lung cancer risk," officials said.